EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Rational design of organometallic therapeutics: leveraging metal–metal bonds for biomedical innovation

Kushneet Kaur Sodhi, Vaishnavi Rajagopalan, Nitin V, Khushi Prajapati, Priyanka Biswas, Chandra Kant Singh

Future Medicinal Chemistry · 2026

DOI: 10.1080/17568919.2026.2620364 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, 2026. Verfasst von Kushneet Kaur Sodhi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Sri Guru Tegh Bahadur Khalsa College, University of Delhi, Delhi, India. Hauptthemen laut MEDLINE: Drug Design, Organometallic Compounds, Metals, Coordination Complexes. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metal-metal interactions play a crucial role in determining the molecular geometry, stability, and biological activity of many compounds. In recent years, organometallic compounds have gained significant importance in medicinal chemistry due to their structural and functional properties in treating various ailments. A virtually limitless number of structures and conformations can result from the enormous range of oxidation states, coordination numbers, and geometries that metal ion coordination complexes and organometallic compounds can adopt, depending on their nature. Understanding the types of metal-metal bonds formed by various elements across the periodic table, their thermodynamic and electronic properties, and their influence on physicochemical properties such as lipophilicity, solubility, and bioavailability becomes essential. Various drug design strategies employ approaches that involve metal-metal bonding, supported by ligand engineering, bridging ligands, and supramolecular or bimetallic complexes. However, off-target effects, toxicity, complexity, stability issues and regulatory considerations pose as key challenges in this task. Future directions focus on emerging applications of metallopharmaceuticals in cancer, antibacterial therapies, as well as their integration with nanotechnology and advanced drug delivery. This review highlights the insights into the concepts of metal-metal interactions, which are crucial for expanding the scope and applications of medicinal chemistry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignOrganometallic CompoundsMetalsCoordination ComplexesHumansAntineoplastic AgentsAnimalsNeoplasms

Stichwörter der Autor:innen

Anticancerantimicrobialmetal-metalorganometallicstransition metals

Substanzen

Organometallic CompoundsMetalsAntineoplastic AgentsCoordination Complexes

Autor:innen und Institutionen

  • Department of Zoology, Sri Guru Tegh Bahadur Khalsa College, University of Delhi, Delhi, India.
  • Department of Zoology, University of Delhi, Delhi, India.

Zitieren

APA

Sodhi, K. K., Rajagopalan, V., V, N., Prajapati, K., Biswas, P., & Singh, C. K. (2026). Rational design of organometallic therapeutics: leveraging metal–metal bonds for biomedical innovation. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2026.2620364

Vancouver

Sodhi KK, Rajagopalan V, V N, Prajapati K, Biswas P, Singh CK. Rational design of organometallic therapeutics: leveraging metal–metal bonds for biomedical innovation. Future Medicinal Chemistry. 2026. doi:10.1080/17568919.2026.2620364

BibTeX
@article{Sodhi2026,
  author = {Sodhi, Kushneet Kaur and Rajagopalan, Vaishnavi and V, Nitin and Prajapati, Khushi and Biswas, Priyanka and Singh, Chandra Kant},
  title = {Rational design of organometallic therapeutics: leveraging metal–metal bonds for biomedical innovation},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  doi = {10.1080/17568919.2026.2620364}
}
Kostenlos starten →